Dynavax Technologies Corp (DVAX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current DVAX market cap is 1.49B. The company's latest EPS is USD -0.0488 and P/E is -233.81.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 60.25M | 69.51M | 55.6M | 50.79M | 73.79M |
| Operating Income | -3.41M | 4.12M | -8.49M | -17.77M | 5.2M |
| Net Income | 3.43M | 14.29M | 219k | -8.72M | 11.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35.22M | 46.55M | 439.44M | 722.68M | 232.28M |
| Operating Income | -134.84M | -75.22M | 133.49M | 282.52M | -25.72M |
| Net Income | -155.87M | -75.24M | 72.14M | 292.87M | -6.39M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 936.43M | 972.93M | 997.1M | 986.57M | 1.02B |
| Total Liabilities | 359.23M | 368.02M | 375.02M | 368.09M | 373.47M |
| Total Equity | 577.21M | 604.92M | 622.07M | 618.48M | 642.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 279.07M | 353.27M | 1.04B | 985.85M | 997.1M |
| Total Liabilities | 270.78M | 294.58M | 816.87M | 404.84M | 375.02M |
| Total Equity | 8.29M | 58.69M | 222.37M | 581.01M | 622.07M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 55.67M | 86.8M | 100.56M | -16.68M | -5.97M |
| Investing | -27.61M | -133.69M | -153.93M | 2.83M | -25.94M |
| Financing | -3.38M | -390k | 1.39M | -4.2M | -5.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -121.25M | -92.25M | 335.53M | 62.72M | 100.56M |
| Investing | -42.78M | -26.53M | 14.23M | -316M | -153.93M |
| Financing | 154.35M | 109.5M | 55.78M | 19.53M | 1.39M |
| Market Cap | 1.49B |
| Price to Earnings Ratio | -233.81 |
| Price to Sales Ratio | 6.44 |
| Price to Cash Ratio | 9.95 |
| Price to Book Ratio | 2.4 |
| Dividend Yield | - |
| Shares Outstanding | 131.04M |
| Average Volume (1 week) | 1.72M |
| Average Volume (1 Month) | 1.93M |
| 52 Week Change | -16.11% |
| 52 Week High | 15.15 |
| 52 Week Low | 9.74 |
| Spread (Intraday) | 0.01 (0.09%) |
| Company Name | Dynavax Technologies Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dynavax.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
